

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | folic acid-containing compound biosynthetic process (GO:0009396) | 9.70877964 |
| 2 | sulfur amino acid catabolic process (GO:0000098) | 8.90579545 |
| 3 | cysteine metabolic process (GO:0006534) | 8.32572481 |
| 4 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 7.76703974 |
| 5 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 7.76703974 |
| 6 | microtubule nucleation (GO:0007020) | 7.73906557 |
| 7 | white fat cell differentiation (GO:0050872) | 7.66574011 |
| 8 | desmosome organization (GO:0002934) | 7.54423174 |
| 9 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 7.34161022 |
| 10 | purine nucleotide salvage (GO:0032261) | 7.24219579 |
| 11 | adenosine metabolic process (GO:0046085) | 6.42455188 |
| 12 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.42311757 |
| 13 | alternative mRNA splicing, via spliceosome (GO:0000380) | 6.21044651 |
| 14 | cell migration involved in heart development (GO:0060973) | 6.18744060 |
| 15 | negative regulation of DNA biosynthetic process (GO:2000279) | 6.13128346 |
| 16 | pteridine-containing compound biosynthetic process (GO:0042559) | 6.02574434 |
| 17 | L-serine metabolic process (GO:0006563) | 5.92881574 |
| 18 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.63343083 |
| 19 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 5.44439127 |
| 20 | negative regulation of catenin import into nucleus (GO:0035414) | 5.40759938 |
| 21 | inner ear receptor cell development (GO:0060119) | 5.36165151 |
| 22 | galactose catabolic process (GO:0019388) | 5.34012751 |
| 23 | negative regulation of Ras GTPase activity (GO:0034261) | 5.32373707 |
| 24 | regulation of tight junction assembly (GO:2000810) | 5.31181128 |
| 25 | mitochondrial RNA metabolic process (GO:0000959) | 5.25023857 |
| 26 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.23750220 |
| 27 | regulation of vitamin metabolic process (GO:0030656) | 5.18903955 |
| 28 | folic acid-containing compound metabolic process (GO:0006760) | 5.04062759 |
| 29 | tetrahydrofolate metabolic process (GO:0046653) | 4.89564158 |
| 30 | serine family amino acid biosynthetic process (GO:0009070) | 4.87549769 |
| 31 | histone H4-K12 acetylation (GO:0043983) | 4.77546136 |
| 32 | galactose metabolic process (GO:0006012) | 4.76617054 |
| 33 | regulation of gonadotropin secretion (GO:0032276) | 4.75270894 |
| 34 | IMP biosynthetic process (GO:0006188) | 4.65073409 |
| 35 | phosphatidylglycerol biosynthetic process (GO:0006655) | 4.62459299 |
| 36 | protein-chromophore linkage (GO:0018298) | 4.56550711 |
| 37 | cartilage morphogenesis (GO:0060536) | 4.47480683 |
| 38 | response to vitamin A (GO:0033189) | 4.41893680 |
| 39 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 4.23760939 |
| 40 | nucleotide salvage (GO:0043173) | 4.23159160 |
| 41 | regulation of sequestering of triglyceride (GO:0010889) | 4.22009855 |
| 42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.19144101 |
| 43 | cochlea development (GO:0090102) | 4.18040023 |
| 44 | folic acid metabolic process (GO:0046655) | 4.15066117 |
| 45 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 4.06241487 |
| 46 | COPII vesicle coating (GO:0048208) | 4.02022801 |
| 47 | IMP metabolic process (GO:0046040) | 3.96872261 |
| 48 | folic acid transport (GO:0015884) | 3.96435748 |
| 49 | negative regulation of cell size (GO:0045792) | 3.91823536 |
| 50 | negative regulation of telomerase activity (GO:0051974) | 3.91794945 |
| 51 | negative regulation of alcohol biosynthetic process (GO:1902931) | 3.90298067 |
| 52 | regulation of cholesterol storage (GO:0010885) | 3.88126923 |
| 53 | pteridine-containing compound metabolic process (GO:0042558) | 3.87571679 |
| 54 | regulation of endothelial cell differentiation (GO:0045601) | 3.81803807 |
| 55 | primary amino compound metabolic process (GO:1901160) | 3.81456116 |
| 56 | response to lipoprotein particle (GO:0055094) | 3.75986933 |
| 57 | sulfur amino acid biosynthetic process (GO:0000097) | 3.73975373 |
| 58 | negative regulation of anoikis (GO:2000811) | 3.73314854 |
| 59 | serine family amino acid catabolic process (GO:0009071) | 3.68896862 |
| 60 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.63775619 |
| 61 | innervation (GO:0060384) | 3.63156044 |
| 62 | nucleoside transmembrane transport (GO:1901642) | 3.59107795 |
| 63 | polyamine biosynthetic process (GO:0006596) | 3.57776404 |
| 64 | energy homeostasis (GO:0097009) | 3.51683874 |
| 65 | one-carbon metabolic process (GO:0006730) | 3.49569248 |
| 66 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.49073778 |
| 67 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.46970225 |
| 68 | rRNA methylation (GO:0031167) | 3.44720317 |
| 69 | organic cation transport (GO:0015695) | 3.42995595 |
| 70 | tRNA modification (GO:0006400) | 3.40684972 |
| 71 | sulfur amino acid metabolic process (GO:0000096) | 3.39564972 |
| 72 | peptidyl-proline hydroxylation (GO:0019511) | 3.37640516 |
| 73 | 4-hydroxyproline metabolic process (GO:0019471) | 3.33490954 |
| 74 | regulation of DNA biosynthetic process (GO:2000278) | 3.33310947 |
| 75 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.31228058 |
| 76 | negative regulation of stem cell proliferation (GO:2000647) | 3.30992960 |
| 77 | glycoside metabolic process (GO:0016137) | 3.29448652 |
| 78 | glycosphingolipid catabolic process (GO:0046479) | 3.27778407 |
| 79 | acrosome assembly (GO:0001675) | 3.20944103 |
| 80 | cellular protein complex localization (GO:0034629) | 3.17287643 |
| 81 | behavioral fear response (GO:0001662) | 3.16592312 |
| 82 | behavioral defense response (GO:0002209) | 3.16592312 |
| 83 | positive regulation of histone acetylation (GO:0035066) | 3.15481596 |
| 84 | neural crest cell development (GO:0014032) | 3.14967449 |
| 85 | muscle atrophy (GO:0014889) | 3.13697739 |
| 86 | alpha-amino acid biosynthetic process (GO:1901607) | 3.13254933 |
| 87 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.12902938 |
| 88 | growth hormone secretion (GO:0030252) | 3.12452807 |
| 89 | cardiac epithelial to mesenchymal transition (GO:0060317) | 3.10681143 |
| 90 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.00397393 |
| 91 | regulation of anoikis (GO:2000209) | 2.97134174 |
| 92 | response to parathyroid hormone (GO:0071107) | 2.93732862 |
| 93 | response to mercury ion (GO:0046689) | 2.91345160 |
| 94 | chromosome condensation (GO:0030261) | 2.90917159 |
| 95 | hepatocyte apoptotic process (GO:0097284) | 2.90784064 |
| 96 | purine-containing compound salvage (GO:0043101) | 2.90718727 |
| 97 | glycolipid catabolic process (GO:0019377) | 2.90537575 |
| 98 | cellular modified amino acid catabolic process (GO:0042219) | 2.86645723 |
| 99 | homocysteine metabolic process (GO:0050667) | 10.8433472 |
| 100 | regulation of plasminogen activation (GO:0010755) | 10.7463973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 5.02901797 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.06304171 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.57816974 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.07728747 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.78842503 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.71243633 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.36926633 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.28071100 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.14756958 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04617011 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 10.3854705 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.78714195 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77572956 |
| 14 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.75689687 |
| 15 | P68_20966046_ChIP-Seq_HELA_Human | 1.73946061 |
| 16 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.69891574 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.64123858 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63080538 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60448791 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58688489 |
| 21 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.49710080 |
| 22 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.48335112 |
| 23 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.47866584 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.46704444 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.45446482 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38515448 |
| 27 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.37971696 |
| 28 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.36608295 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34775986 |
| 30 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.34673637 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34398861 |
| 32 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.34316646 |
| 33 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.33910395 |
| 34 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.33757799 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33522412 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33250891 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.32857453 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.32586195 |
| 39 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31720523 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30230984 |
| 41 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28814740 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.28122152 |
| 43 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28056150 |
| 44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27762483 |
| 45 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26777855 |
| 46 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.26409968 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25393223 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24387986 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24020948 |
| 50 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20497363 |
| 51 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.19879909 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19502261 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19311374 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19144758 |
| 55 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.18098738 |
| 56 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17571509 |
| 57 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.15236416 |
| 58 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11759415 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10654830 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10053132 |
| 61 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09411243 |
| 62 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09265694 |
| 63 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.08607852 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08515692 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08099073 |
| 66 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05709137 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02583173 |
| 68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02441776 |
| 69 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00993913 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00712574 |
| 71 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99741356 |
| 72 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99046262 |
| 73 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96282967 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95734270 |
| 75 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94768296 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93795515 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92675365 |
| 78 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92239245 |
| 79 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91824280 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90784140 |
| 81 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90286399 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89758823 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.89618275 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.88813771 |
| 85 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88293534 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87767859 |
| 87 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.87565473 |
| 88 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.85455659 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85117592 |
| 90 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.84879844 |
| 91 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84765579 |
| 92 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84146794 |
| 93 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.83647462 |
| 94 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82590748 |
| 95 | MAF_26560356_Chip-Seq_TH1_Human | 0.82457521 |
| 96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.82183320 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82024025 |
| 98 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.81657163 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81564554 |
| 100 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81292053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 7.27926098 |
| 2 | MP0005360_urolithiasis | 6.75823456 |
| 3 | MP0005670_abnormal_white_adipose | 5.33504319 |
| 4 | MP0003183_abnormal_peptide_metabolism | 4.32748908 |
| 5 | MP0000013_abnormal_adipose_tissue | 4.01328417 |
| 6 | MP0005646_abnormal_pituitary_gland | 3.97697157 |
| 7 | MP0001661_extended_life_span | 3.76907774 |
| 8 | MP0002396_abnormal_hematopoietic_system | 3.60092383 |
| 9 | MP0008995_early_reproductive_senescence | 3.34641244 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 3.02434223 |
| 11 | MP0003724_increased_susceptibility_to | 2.83990522 |
| 12 | MP0000003_abnormal_adipose_tissue | 2.25464757 |
| 13 | MP0004885_abnormal_endolymph | 2.08827732 |
| 14 | MP0002938_white_spotting | 1.96582675 |
| 15 | MP0002132_abnormal_respiratory_system | 1.89762728 |
| 16 | MP0000516_abnormal_urinary_system | 1.88005938 |
| 17 | MP0005367_renal/urinary_system_phenotyp | 1.88005938 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 1.82204200 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.75636429 |
| 20 | MP0005332_abnormal_amino_acid | 1.75494784 |
| 21 | MP0005076_abnormal_cell_differentiation | 1.75327909 |
| 22 | MP0001851_eye_inflammation | 1.72266345 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.66023806 |
| 24 | MP0002736_abnormal_nociception_after | 1.62123819 |
| 25 | MP0004147_increased_porphyrin_level | 1.55341891 |
| 26 | MP0004130_abnormal_muscle_cell | 1.52609371 |
| 27 | MP0000534_abnormal_ureter_morphology | 1.45760080 |
| 28 | MP0000371_diluted_coat_color | 1.32569828 |
| 29 | MP0000566_synostosis | 1.27533710 |
| 30 | MP0001764_abnormal_homeostasis | 1.25909999 |
| 31 | MP0003186_abnormal_redox_activity | 1.23654939 |
| 32 | MP0002095_abnormal_skin_pigmentation | 1.22826309 |
| 33 | MP0004233_abnormal_muscle_weight | 1.14212399 |
| 34 | MP0004043_abnormal_pH_regulation | 1.12795233 |
| 35 | MP0005164_abnormal_response_to | 1.12527175 |
| 36 | MP0003045_fibrosis | 1.05561724 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.00709637 |
| 38 | MP0003436_decreased_susceptibility_to | 1.00358572 |
| 39 | MP0000678_abnormal_parathyroid_gland | 1.00137134 |
| 40 | MP0008872_abnormal_physiological_respon | 0.99100454 |
| 41 | MP0009643_abnormal_urine_homeostasis | 0.98071250 |
| 42 | MP0009115_abnormal_fat_cell | 0.97120817 |
| 43 | MP0001533_abnormal_skeleton_physiology | 0.95274729 |
| 44 | MP0000762_abnormal_tongue_morphology | 0.95019789 |
| 45 | MP0000747_muscle_weakness | 0.90340129 |
| 46 | MP0003786_premature_aging | 0.88898036 |
| 47 | MP0004947_skin_inflammation | 0.84660914 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 0.84582132 |
| 49 | MP0003942_abnormal_urinary_system | 0.84242014 |
| 50 | MP0001944_abnormal_pancreas_morphology | 0.79434516 |
| 51 | MP0000647_abnormal_sebaceous_gland | 0.78195271 |
| 52 | MP0001849_ear_inflammation | 0.77475422 |
| 53 | MP0001270_distended_abdomen | 0.77158706 |
| 54 | MP0001340_abnormal_eyelid_morphology | 0.76445046 |
| 55 | MP0001756_abnormal_urination | 0.76023957 |
| 56 | MP0000750_abnormal_muscle_regeneration | 0.75525616 |
| 57 | MP0005666_abnormal_adipose_tissue | 0.74469102 |
| 58 | MP0005376_homeostasis/metabolism_phenot | 0.73570683 |
| 59 | MP0001800_abnormal_humoral_immune | 0.73162175 |
| 60 | MP0002060_abnormal_skin_morphology | 0.72262894 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 0.71850961 |
| 62 | MP0002971_abnormal_brown_adipose | 0.71514205 |
| 63 | MP0002009_preneoplasia | 0.70841411 |
| 64 | MP0005375_adipose_tissue_phenotype | 0.70570442 |
| 65 | MP0001216_abnormal_epidermal_layer | 0.69052378 |
| 66 | MP0000026_abnormal_inner_ear | 0.69016729 |
| 67 | MP0009697_abnormal_copulation | 0.68346871 |
| 68 | MP0005334_abnormal_fat_pad | 0.68309683 |
| 69 | MP0005000_abnormal_immune_tolerance | 0.67510213 |
| 70 | MP0000703_abnormal_thymus_morphology | 0.64134510 |
| 71 | MP0002006_tumorigenesis | 0.63808662 |
| 72 | MP0000733_abnormal_muscle_development | 0.60094762 |
| 73 | MP0002069_abnormal_eating/drinking_beha | 0.59246474 |
| 74 | MP0002735_abnormal_chemical_nociception | 0.59242920 |
| 75 | MP0000858_altered_metastatic_potential | 0.58574995 |
| 76 | MP0001968_abnormal_touch/_nociception | 0.56928117 |
| 77 | MP0002075_abnormal_coat/hair_pigmentati | 0.55711183 |
| 78 | MP0002933_joint_inflammation | 0.55118193 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 0.55060062 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 0.53362353 |
| 81 | MP0002419_abnormal_innate_immunity | 0.53315768 |
| 82 | MP0002970_abnormal_white_adipose | 0.52631362 |
| 83 | MP0001502_abnormal_circadian_rhythm | 0.52497517 |
| 84 | MP0005365_abnormal_bile_salt | 0.52273466 |
| 85 | MP0002108_abnormal_muscle_morphology | 0.51640285 |
| 86 | MP0003252_abnormal_bile_duct | 0.51628917 |
| 87 | MP0000598_abnormal_liver_morphology | 0.50116759 |
| 88 | MP0005083_abnormal_biliary_tract | 0.49863558 |
| 89 | MP0005595_abnormal_vascular_smooth | 0.49123827 |
| 90 | MP0004133_heterotaxia | 0.47334899 |
| 91 | MP0002269_muscular_atrophy | 0.47307087 |
| 92 | MP0001243_abnormal_dermal_layer | 0.46455983 |
| 93 | MP0003315_abnormal_perineum_morphology | 0.46311684 |
| 94 | MP0002452_abnormal_antigen_presenting | 0.45955070 |
| 95 | MP0002723_abnormal_immune_serum | 0.45059361 |
| 96 | MP0003115_abnormal_respiratory_system | 0.44217285 |
| 97 | MP0000249_abnormal_blood_vessel | 0.43728271 |
| 98 | MP0004134_abnormal_chest_morphology | 0.43516244 |
| 99 | MP0009931_abnormal_skin_appearance | 0.43461475 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.42088923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 8.99969259 |
| 2 | Abnormality of alanine metabolism (HP:0010916) | 8.99969259 |
| 3 | Hyperalaninemia (HP:0003348) | 8.99969259 |
| 4 | Spontaneous hematomas (HP:0007420) | 7.10195914 |
| 5 | Constricted visual fields (HP:0001133) | 6.47530589 |
| 6 | Esophageal varix (HP:0002040) | 6.10976697 |
| 7 | Congenital sensorineural hearing impairment (HP:0008527) | 5.44431608 |
| 8 | Abnormality of the fetal cardiovascular system (HP:0010948) | 5.23728332 |
| 9 | Abnormal umbilical cord blood vessels (HP:0011403) | 5.23728332 |
| 10 | Single umbilical artery (HP:0001195) | 5.23728332 |
| 11 | Myocardial infarction (HP:0001658) | 4.89476070 |
| 12 | White forelock (HP:0002211) | 4.83727581 |
| 13 | Abnormality of homocysteine metabolism (HP:0010919) | 4.38633898 |
| 14 | Homocystinuria (HP:0002156) | 4.38633898 |
| 15 | Patchy hypopigmentation of hair (HP:0011365) | 4.16210595 |
| 16 | Anorexia (HP:0002039) | 4.10294714 |
| 17 | Conjunctival telangiectasia (HP:0000524) | 4.08264673 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.00614359 |
| 19 | Birth length less than 3rd percentile (HP:0003561) | 3.76050837 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 3.64497893 |
| 21 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.57766806 |
| 22 | Pulmonary embolism (HP:0002204) | 3.56500566 |
| 23 | Abnormality of the umbilical cord (HP:0010881) | 3.52600491 |
| 24 | Visceral angiomatosis (HP:0100761) | 3.51574577 |
| 25 | Action tremor (HP:0002345) | 3.46924817 |
| 26 | Fatigue (HP:0012378) | 3.44204017 |
| 27 | Biconcave vertebral bodies (HP:0004586) | 3.35697773 |
| 28 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.31625333 |
| 29 | Heterochromia iridis (HP:0001100) | 3.31155965 |
| 30 | Chronic otitis media (HP:0000389) | 3.28386412 |
| 31 | Hemangiomatosis (HP:0007461) | 3.21553795 |
| 32 | Abnormality of serum amino acid levels (HP:0003112) | 3.17764944 |
| 33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.06510936 |
| 34 | Poor speech (HP:0002465) | 2.96889756 |
| 35 | Myopathic facies (HP:0002058) | 2.88396300 |
| 36 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.84673919 |
| 37 | Oligomenorrhea (HP:0000876) | 2.81956881 |
| 38 | Thrombophlebitis (HP:0004418) | 2.74829037 |
| 39 | Toxemia of pregnancy (HP:0100603) | 2.67594734 |
| 40 | Hypopigmentation of the fundus (HP:0007894) | 2.57312610 |
| 41 | Disproportionate tall stature (HP:0001519) | 2.50766763 |
| 42 | Ileus (HP:0002595) | 2.49422782 |
| 43 | Polygenic inheritance (HP:0010982) | 2.48574589 |
| 44 | Pigmentary retinal degeneration (HP:0001146) | 2.46511709 |
| 45 | Decreased subcutaneous fat (HP:0001002) | 2.44531745 |
| 46 | Generalized aminoaciduria (HP:0002909) | 2.39444503 |
| 47 | Gingival bleeding (HP:0000225) | 2.29059564 |
| 48 | Cone-rod dystrophy (HP:0000548) | 2.28129841 |
| 49 | Arterial thrombosis (HP:0004420) | 2.25392694 |
| 50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.22557474 |
| 51 | Cortical visual impairment (HP:0100704) | 2.19505500 |
| 52 | Arteriovenous malformation (HP:0100026) | 2.19196161 |
| 53 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.17946484 |
| 54 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.16670164 |
| 55 | Peritonitis (HP:0002586) | 2.15643327 |
| 56 | Maternal diabetes (HP:0009800) | 2.14184013 |
| 57 | Cavernous hemangioma (HP:0001048) | 2.13540127 |
| 58 | Elevated alkaline phosphatase (HP:0003155) | 2.09236544 |
| 59 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.08053489 |
| 60 | Hypolipoproteinemia (HP:0010981) | 2.02746337 |
| 61 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.01678177 |
| 62 | Complete atrioventricular canal defect (HP:0001674) | 2.01219026 |
| 63 | Chorioretinal atrophy (HP:0000533) | 1.98352143 |
| 64 | Epidermoid cyst (HP:0200040) | 1.96535738 |
| 65 | Hyperuricemia (HP:0002149) | 1.95490738 |
| 66 | Increased purine levels (HP:0004368) | 1.95490738 |
| 67 | Duplicated collecting system (HP:0000081) | 1.94441553 |
| 68 | Chronic hepatic failure (HP:0100626) | 1.93338562 |
| 69 | Flat acetabular roof (HP:0003180) | 1.91811551 |
| 70 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.91802879 |
| 71 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91207454 |
| 72 | Recurrent abscess formation (HP:0002722) | 1.90361391 |
| 73 | Diaphragmatic weakness (HP:0009113) | 1.86913797 |
| 74 | Hypoplastic left heart (HP:0004383) | 1.86861718 |
| 75 | Attenuation of retinal blood vessels (HP:0007843) | 1.85156172 |
| 76 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84952619 |
| 77 | Abnormality of the fingertips (HP:0001211) | 1.82980133 |
| 78 | Nausea (HP:0002018) | 1.81472093 |
| 79 | Abnormality of the renal collecting system (HP:0004742) | 1.81386186 |
| 80 | Hemoptysis (HP:0002105) | 1.78930949 |
| 81 | Microcytic anemia (HP:0001935) | 1.78771797 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 1.77877976 |
| 83 | Pustule (HP:0200039) | 1.77578434 |
| 84 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.76730824 |
| 85 | Petechiae (HP:0000967) | 1.75900857 |
| 86 | Duplication of thumb phalanx (HP:0009942) | 1.75877103 |
| 87 | Myositis (HP:0100614) | 1.75055485 |
| 88 | Thin ribs (HP:0000883) | 1.74078863 |
| 89 | Clonus (HP:0002169) | 1.72358604 |
| 90 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.70893600 |
| 91 | Abnormal tarsal ossification (HP:0008369) | 1.68337769 |
| 92 | Portal hypertension (HP:0001409) | 1.65498150 |
| 93 | Epistaxis (HP:0000421) | 1.65187759 |
| 94 | Gastrointestinal dysmotility (HP:0002579) | 1.64906537 |
| 95 | Focal segmental glomerulosclerosis (HP:0000097) | 1.63366672 |
| 96 | Pendular nystagmus (HP:0012043) | 1.62622262 |
| 97 | Premature graying of hair (HP:0002216) | 1.61578277 |
| 98 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.60018454 |
| 99 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.60018454 |
| 100 | Persistence of primary teeth (HP:0006335) | 1.58804645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K3 | 6.22613277 |
| 2 | MAP3K3 | 6.21491213 |
| 3 | JAK3 | 3.93511215 |
| 4 | FGR | 3.52391449 |
| 5 | CDK9 | 3.51425830 |
| 6 | ACVR1B | 3.17342387 |
| 7 | RPS6KB2 | 2.94876354 |
| 8 | MAP4K1 | 2.63166384 |
| 9 | SGK494 | 2.54581456 |
| 10 | SGK223 | 2.54581456 |
| 11 | EPHB2 | 2.45453651 |
| 12 | NTRK2 | 2.36992358 |
| 13 | TRIB3 | 2.25092625 |
| 14 | SGK2 | 2.18897912 |
| 15 | ERN1 | 1.89304016 |
| 16 | SMG1 | 1.88854354 |
| 17 | SGK3 | 1.87253108 |
| 18 | CCNB1 | 1.60860432 |
| 19 | LMTK2 | 1.59969228 |
| 20 | MAP3K11 | 1.57890515 |
| 21 | CDK12 | 1.54903940 |
| 22 | PAK4 | 1.44707920 |
| 23 | PKN2 | 1.39042618 |
| 24 | MAP2K1 | 1.35786574 |
| 25 | PTK6 | 1.35404449 |
| 26 | SIK1 | 1.32779929 |
| 27 | MTOR | 1.27909898 |
| 28 | NTRK3 | 1.27476199 |
| 29 | CAMK1D | 1.14059041 |
| 30 | NEK6 | 1.09068174 |
| 31 | PRPF4B | 1.07868626 |
| 32 | STK10 | 1.05990164 |
| 33 | ADRBK1 | 1.01938471 |
| 34 | IRAK4 | 0.90763540 |
| 35 | IRAK3 | 0.90163886 |
| 36 | CDK7 | 0.84300846 |
| 37 | ICK | 0.82532203 |
| 38 | HIPK2 | 0.79684805 |
| 39 | IRAK2 | 0.75907236 |
| 40 | CAMK1 | 0.75703891 |
| 41 | AURKA | 0.71361503 |
| 42 | JAK2 | 0.70193925 |
| 43 | CDK6 | 0.69905870 |
| 44 | RPS6KA1 | 0.69366585 |
| 45 | RPS6KB1 | 0.68807273 |
| 46 | CSNK1A1 | 0.67342537 |
| 47 | TTN | 0.66392703 |
| 48 | DYRK1B | 0.58946434 |
| 49 | PRKCI | 0.58010095 |
| 50 | SGK1 | 0.55966329 |
| 51 | UHMK1 | 0.53939640 |
| 52 | EPHA2 | 0.51372027 |
| 53 | IKBKB | 0.47779581 |
| 54 | BRD4 | 0.46365531 |
| 55 | INSR | 0.45067089 |
| 56 | RPS6KL1 | 0.44513742 |
| 57 | RPS6KC1 | 0.44513742 |
| 58 | CAMK1G | 0.44145628 |
| 59 | CAMK2B | 0.41849740 |
| 60 | PRKCD | 0.40239377 |
| 61 | GRK6 | 0.38786137 |
| 62 | RPS6KA6 | 0.38288854 |
| 63 | TNK2 | 0.38255807 |
| 64 | MAPK8 | 0.38052658 |
| 65 | PRKD1 | 0.37353113 |
| 66 | EEF2K | 0.37332126 |
| 67 | MAPKAPK2 | 0.37188464 |
| 68 | MAP3K7 | 0.36380573 |
| 69 | PIM2 | 0.35487638 |
| 70 | MAP3K1 | 0.35336476 |
| 71 | MST1R | 0.34845569 |
| 72 | PRKD3 | 0.33137445 |
| 73 | LCK | 0.31561751 |
| 74 | SYK | 0.31403802 |
| 75 | IRAK1 | 0.31311925 |
| 76 | AKT1 | 0.30960405 |
| 77 | BLK | 0.30080152 |
| 78 | PRKD2 | 0.30025734 |
| 79 | BTK | 0.29716367 |
| 80 | YES1 | 0.29557167 |
| 81 | TBK1 | 0.29501202 |
| 82 | EGFR | 0.29304615 |
| 83 | MAP3K8 | 0.28650711 |
| 84 | MAPK11 | 0.27491831 |
| 85 | AKT2 | 0.26561486 |
| 86 | TAOK2 | 0.25883488 |
| 87 | PIM1 | 0.24658306 |
| 88 | MAP3K10 | 0.24156026 |
| 89 | PRKG2 | 0.23785240 |
| 90 | ATR | 0.23316540 |
| 91 | CAMK2D | 0.22832611 |
| 92 | CAMK2G | 0.21575736 |
| 93 | CDK2 | 0.21224224 |
| 94 | CDC42BPA | 0.20488468 |
| 95 | PRKCQ | 0.18449212 |
| 96 | CDK4 | 0.18212374 |
| 97 | MAPK1 | 0.17963670 |
| 98 | MAPK7 | 0.17687909 |
| 99 | RIPK1 | 0.17434031 |
| 100 | FGFR4 | 0.17144513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | One carbon pool by folate_Homo sapiens_hsa00670 | 5.41912944 |
| 2 | Arginine biosynthesis_Homo sapiens_hsa00220 | 5.23429662 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.10605125 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 3.73028619 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.33568536 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.28180857 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 2.97635613 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.58346256 |
| 9 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.52162944 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35648869 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.35561425 |
| 12 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.28441753 |
| 13 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.07077234 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.06188941 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.82549721 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.81754739 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.76194535 |
| 18 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.75389251 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.65664507 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.44447535 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.43065882 |
| 22 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.37293472 |
| 23 | Thyroid cancer_Homo sapiens_hsa05216 | 1.32063928 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21142925 |
| 25 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.10637721 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05129381 |
| 27 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.03954937 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00727439 |
| 29 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.96789372 |
| 30 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96191641 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.94004392 |
| 32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92513554 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92206205 |
| 34 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.90352321 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90186929 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89426799 |
| 37 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.87039291 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.85921468 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85448697 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 0.74987908 |
| 41 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73543905 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71787239 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70911107 |
| 44 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.69890627 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69839985 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64963206 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.63653886 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61974179 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.58083570 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.56785233 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53081886 |
| 52 | Circadian entrainment_Homo sapiens_hsa04713 | 0.51965269 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50336809 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50264302 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.49629472 |
| 56 | Alcoholism_Homo sapiens_hsa05034 | 0.48946538 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45070173 |
| 58 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44280442 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42055955 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41174765 |
| 61 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41104001 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41103790 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40576525 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.39026624 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36819757 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35717849 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35573096 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33055361 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.32487418 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31353329 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.31191085 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.31167862 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29112825 |
| 74 | Base excision repair_Homo sapiens_hsa03410 | 0.28956279 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27537870 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.27016283 |
| 77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.26669501 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25587284 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.24534718 |
| 80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.23700628 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.23694476 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.21474172 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21265825 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.21153020 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.21151193 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17192279 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.17061675 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15984636 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15964297 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.15126010 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.13641659 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13532057 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.12544559 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.12309611 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.10962084 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.10525612 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.09999137 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.09916252 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.09722247 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.09076739 |

